DHANAK DASHYANT (EVP & Chief Scientific Officer) received a stock award from DECIPHERA PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/11/2024ACC: 0000950170-24-072214
Officer· EVP & Chief Scientific Officer
Since Sep 2023
-293.18K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
25.91K acquired · 319.09K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+25.91K
Price / share
—
Trade value
—
% of position
16.4%
6/11/2024
158.18K→184.09K
Common Stock
Direct
Shares
−184.09K
Price / share
—
Trade value
—
% of position
New position
6/11/2024
184.09K→0.00
Total
Net shares
−158.18K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2024 | A · Award | +25.91K | — | — | 16.4% | 158.18K | 184.09K |
| Common Stock Direct | 6/11/2024 | D · Disposition | −184.09K | — | — | New position | 184.09K | 0.00 |
| Total | −158.18K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
65.90K shares
Shares
−65.90K
Strike price
13.42
Held after
0.00
Exercisable
—
6/11/2024
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
69.10K shares
Shares
−69.10K
Strike price
15.92
Held after
0.00
Exercisable
—
6/11/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock65.90K shares | 6/11/2024 | D · Disposition | −65.90K | 13.42 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock69.10K shares | 6/11/2024 | D · Disposition | −69.10K | 15.92 | — | 0.00 |